Investment Analysts’ Weekly Ratings Changes for Ralliant (RAL)

Ralliant (NYSE: RAL) recently received a number of ratings updates from brokerages and research firms:

• 6/30/2026 – Ralliant was upgraded by Zacks Research from “hold” to “strong-buy”.
• 6/28/2026 – Ralliant was downgraded by Wall Street Zen from “buy” to “hold”.
• 6/23/2026 – Ralliant had its price target raised by Morgan Stanley from $68.00 to $85.00. They now have an “overweight” rating on the stock.
• 6/20/2026 – Ralliant was upgraded by Wall Street Zen from “hold” to “buy”.
• 6/9/2026 – Ralliant is now covered by Evercore Inc. They set an “outperform” rating and a $80.00 price target on the stock.
• 5/31/2026 – Ralliant was downgraded by Wall Street Zen from “buy” to “hold”.
• 5/27/2026 – Ralliant was downgraded by Vertical Research from “buy” to “hold”. They now have a $65.00 price target on the stock.
• 5/23/2026 – Ralliant was upgraded by Wall Street Zen from “hold” to “buy”.
• 5/20/2026 – Ralliant had its price target raised by TD Cowen from $55.00 to $70.00. They now have a “buy” rating on the stock.
• 5/14/2026 – Ralliant had its price target raised by Morgan Stanley from $45.00 to $68.00. They now have an “overweight” rating on the stock.
• 5/13/2026 – Ralliant had its price target raised by Royal Bank Of Canada from $47.00 to $64.00. They now have a “sector perform” rating on the stock.
• 5/13/2026 – Ralliant had its price target raised by Oppenheimer Holdings, Inc. from $50.00 to $65.00. They now have an “outperform” rating on the stock.
• 5/13/2026 – Ralliant had its price target raised by Citigroup Inc. from $51.00 to $70.00. They now have a “buy” rating on the stock.
• 5/13/2026 – Ralliant had its price target raised by Barclays PLC from $52.00 to $67.00. They now have an “overweight” rating on the stock.
• 5/13/2026 – Ralliant had its “buy” rating reaffirmed by Truist Financial Corporation. They now have a $68.00 price target on the stock, up from $53.00.

Ralliant Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 23rd. Stockholders of record on Monday, June 8th were paid a $0.05 dividend. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date was Monday, June 8th. Ralliant’s dividend payout ratio is -1.83%.

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.